8 Advantages of CardioMetaboliQ

Its All Connected. Every aspect of liver, metabolic and cardiovascular physiology affects every other. To see the risks, and most importantly, the steps to reduce risks, one must look carefully at the Big Picture. That is CardioMetabolIQ’s mission.

By integrating key markers for liver function and fat content, cardio- and cerebrovascular health, and multi-faceted metabolic function, the dried blood spot CardioMetaboliQ test provides a level of utility, scope and value to the user that is first in class.

Most blood panels include liver function markers ALT and AST. These markers are actually not optimal in assessing Fatty Liver. Kotronen A et al, (2009)* demonstrated that as many as 80% of subjects with Fatty Liver were not properly identified using ALT in assessment. 

The Fatty Liver Index used in the CardioMetaboliQ test has been the gold standard for non-invasive Fatty Liver assessment since it was introduced in 2006. Because Fatty Liver significantly worsens cardiovascular, metabolic and many other diseases, getting timely, accurate assessment is vital.

*https://doi.org/10.1053/j.gastro.2009.06.005

Integrative practitioners continuously strive to deliver value to clients. Value requires providing actionable, evidence-based information to patients in a way that is easy to interpret and absorb. 

As an in-home, comprehensive blood spot test, CardioMetaboliQ gives patients unmatched value in assessing and addressing cardiovascular, hepatic, metabolic and cerebrovascular health. And it does all this in the comfort of the patients home, at an affordable price.

So often, test results are delivered as a pile of data. Those that need the information most, the patients, commonly feel overwhelmed and unable to parse the important meaning contained within. 

The CardioMetaboliQ Health Report is a carefully designed hybrid report; containing nuanced and comprehensive information, but presented so the non-technical reader can get the salient facts about their health.

From the comprehensive CardioMetaboliQ Index, to the CardioMetaboliQ-10 steps for success, the Health Report is a valuable, dynamic document. The BioCalculators at CMIQResearch.com further allow users to track, project and understand their personal results and areas of importance.

Clarity is critical. CardioMetaboliQ keeps that in mind with the CardioMetaboliQ Index, a single risk-averaged composite score that combines 10 critical markers from the Health Report. 

Because liver, metabolic, and cardiovascular factors are all involved in cardiometabolic health, we provide a single data point that reflects an aggregate relative risk across the entire cardiometabolic health spectrum.

Note: the CardioMetaboliQ Index is for informational use only.

In the past, heart disease was largely thought to be driven by elevated LDL (“bad”) Cholesterol. Research now shows LDL to be just one of several factors in the atherogenic process, and not necessarily the major player. In fact, fully 50% of heart attacks occur in patients with “normal” LDL Cholesterol.

Science now recognizes  that ”residual risk” factors including Remnant Cholesterol, Atherogenic Index, Inflammation, Oxidative Stress, Insulin Resistance and Fatty Liver represent a substantial portion of cardiovascular risk. A “heart health” test is incomplete without assessing residual risk factors. 

Insulin Resistance (IR) is the cornerstone of cardiometabolic disease. CardioMetaboliQ assess the two most accurate IR values: a) the Triglyceride-Glucose Index (TyG) and b)  TyG-WHtR which includes a Body Composition (anthropometric) factor for added sensitivity.

The Triglyceride-Glucose Index provides excellent relative risk data, mined from over 60 years of NHANES health data, assessing millions of person-years of health and nutrition data. This allows for extensive prospective study, providing vast relative risk insight across numerous cardiovascular, hepatic (liver), neurocognitive and metabolic diseases. 

The accuracy of the TyG is shown to surpass other IR markers, including the most widely referenced HOMA-IR and TG/HDL. And adding Body Composition (WHtR) improves accuracy across various genetic body composition phenotypes.

We know that receiving your test results is just the beginning. At CardioMetaboliQ we focus on giving users the tools for what comes after testing. Our BioCalculator and Research sections provide excellent tools for following through, for next steps.

When a patient registeres their kit, they receive ann email invite to access CMIQResearch.com. CMIQResearch.com provides research and BioCalculator access to all registered test patients.

The BioCalculators allow users to further examine their results, and adjust the parameters and values to determine what changes they can make to reduce their individual risks. CMIQResearch.com is all things cardiometabolic, containing curated research that allows user to further their understanding of cardiometabolic health and wellness.